Evaluation of the MammaTyperVR as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes

被引：0

作者：

Fasching, P. A. ^{[1
]}

Laible, M. ^{[2
]}

Weber, K. E. ^{[3
]}

Wirtz, R. M. ^{[4
]}

Denkert, C. ^{[5
]}

Schlombs, K. ^{[6
]}

Schmatloch, S. ^{[7
]}

Camara, O. ^{[8
]}

Lueck, H. J. ^{[9
]}

Huober, J. ^{[10
]}

Karn, T. ^{[11
]}

van Mackelenbergh, M. T. ^{[12
]}

Marme, F. ^{[13
]}

Mueller, V. ^{[14
]}

Schem, C. ^{[15
]}

Stickeler, E. ^{[16
]}

Sahin, U. ^{[17
]}

Loibl, S. ^{[18
]}

Untch, M. ^{[19
]}

机构：

[1] Univ Klin Erlangen, Dept Gynecol & Obstet, Erlangen, Germany

[2] BioNTech Diagnost GmbH, Gynakol, Mainz, Germany

[3] Forsch GmbH, Stat, German Breast Grp, Neu Isenburg, Germany

[4] STRATIFYER Mol Pathol GmbH, Cologne, Germany

[5] Charite Berlin Mitte, Inst Pathol, Berlin, Germany

[6] BioNTech Diagnost GmbH, Mainz, Germany

[7] Elisabeth Hosp, Brustzentrum, Kassel, Germany

[8] Hufeland Klinikum, Brustzentrum, Bad Langensalza, Germany

[9] Gynakol Onkol Praxis, Gynakol, Hannover, Germany

[10] Univ Frauenklin Ulm, Gynecol & Obstet, Ulm, Germany

[11] Univ Klinikum Frankfurt, Klin Frauenheilkunde & Geburtshilfe, Johannes Wolfgang Goethe Inst, Frankfurt, Germany

[12] Univ Hosp Schleswig Holstein, Clin Gynecol & Obstet, Kiel, Germany

[13] Natl Zentrum Tumorerkrankungen NCT, Gynecol Oncol, Heidelberg, Germany

[14] Hamburg Eppendorf Univ, Dept Gynecol, Med Ctr, Hamburg, Germany

[15] Hosp Jerusalem, Mammazentrum Hamburg, Hamburg, Germany

[16] Uniklin RWTH, Gynakol & Geburtsmed, Aachen, Germany

[17] BioNTech AG, Management, Mainz, Germany

[18] Forsch GmbH, Dept Med & Res, GBG, Neu Isenburg, Germany

[19] Helios Klinikum Berlin Buch, Geburtshilfe & Gynakol, Berlin, Germany

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

227P

引用

页码：73 / 73

页数：1

共 50 条

[1] Validation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)
Fasching, P. A.
Laible, M.
Weber, K. E.
Wirtz, R. M.
Denkert, C.
Schlombs, K.
Schmatloch, S.
Camara, O.
Lueck, H. J.
Huober, J.
Karn, T.
van Mackelenbergh, M. T.
Marme, F.
Mueller, V.
Schem, C.
Stickeler, E.
Sahin, U.
Loibl, S.
Untch, M.
[J]. ANNALS OF ONCOLOGY, 2018, 29 : 53 - 53
[2] PROGESTERONE RECEPTOR (PR) NEGATIVITY PREDICTS PATHOLOGICAL COMPLETE RESPONSE (PCR) AFTER NEOADJUVANT CHEMOTHERAPY (NACT) IN BREAST CANCER (BC) PATIENTS (PTS)
Perez-Garcia, J. M.
Saura, C.
Munoz, E.
Sanchez-Olle, G.
Gomez, P.
Di Cosimo, S.
Sabadell, D.
Cortes, J.
Baselga, J.
Bellet, M.
[J]. ANNALS OF ONCOLOGY, 2009, 20 : 53 - 54
[3] Pathological response and surgical outcome with neoadjuvant chemotherapy (NACT) in Saudi Arabian breast cancer (BC) patients.
Abdelrahman, Hossam A.
Hadedeyah, Deena
Ur-Rehman, Habib
Karim, Syed Mustafa
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[4] Molecular subtypes as a predictor of response to neoadjuvant chemotherapy in breast cancer patients
Shanmugam, Subbiah
Govindasamy, Gopu
Senthilkumar, P.
Muniasamy, P.
[J]. INDIAN JOURNAL OF CANCER, 2017, 54 (04) : 652 - 657
[5] Role of progesterone receptor status (PR) as predictive factor of pathological complete response (pCR) to neoadjuvant chemotherapy (NACT) in breast cancer (BC) patients (pts)
Perez Garcia, J. M., Sr.
Saura, C.
Munoz, E.
Sanchez-Olle, G.
Gomez, P.
Peg, V.
Sabadell, D.
Cortes, J.
Baselga, J.
Bellet, M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[6] Pathological complete response (pCR) after neoadjuvant chemotherapy in luminal breast cancer
Cordoba Ortega, J. F.
Gasol Cudos, A.
Morales Murillo, S.
Vilardell Villellas, F.
Siso Raber, C.
Canosa Morales, C.
Salud Salvia, A.
[J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S313 - S313
[7] Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer
Takaoka, Megumi
Ohsumi, Shozo
Ikejiri, Haruka
Shidahara, Tomohiro
Miyoshi, Yuichiro
Takahashi, Mina
Takashima, Seiki
Aogi, Kenjiro
[J]. ACTA MEDICA OKAYAMA, 2022, 76 (02) : 105 - 111
[8] Pathologic complete response after neoadjuvant chemotherapy in breast cancer molecular subtypes
Sari, E.
Aksoy, S.
Dogan, M.
Altinbas, M.
Zengin, N.
Ozisik, Y.
Altundag, K.
[J]. BREAST, 2015, 24 : S99 - S99
[9] Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer
Zhao, Yue
Dong, Xiaoqiu
Li, Rongguo
Ma, Xiao
Song, Jian
Li, Yingjie
Zhang, Dongwei
[J]. ONCOTARGETS AND THERAPY, 2015, 8 : 1511 - 1521
[10] Assessing the Correlation of Rate of Pathological Complete Response and Outcome in Post Neoadjuvant Chemotherapy Setting and Molecular Subtypes of Breast Cancer
Omair, Ahmad
Alkushi, Abdulmohsen
Alamri, Ghaida
Almojel, Talal
Alsadun, Sara
Masuadi, Emad
Arabi, Haitham
Mohamed, Amin E.
Abulkhair, Omalkhair A.
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)

← 1 2 3 4 5 →